Saracatinib

( DrugBank: Saracatinib / KEGG DRUG: Saracatinib )


3 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease1
89Lymphangioleiomyomatosis2
IDDisease name (Link within this page)Number of trials
272Fibrodysplasia ossificans progressiva2

6. Parkinson disease


Clinical trials : 2,817 / Drugs : 2,606 - (DrugBank : 348) / Drug target genes : 185 - Drug target pathways : 205 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

89. Lymphangioleiomyomatosis


Clinical trials : 44 / Drugs : 54 - (DrugBank : 19) / Drug target genes : 27 - Drug target pathways : 143 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

272. Fibrodysplasia ossificans progressiva


Clinical trials : 55 / Drugs : 51 - (DrugBank : 9) / Drug target genes : 28 - Drug target pathways : 106 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries